Correlation between methylation status of the p16/CDKN2 gene and the expression of p16 and Rb proteins in primary non-small cell lung cancers

International Journal of Cancer

Volumn 79, Issue 3, 1998, Pages 215-220

  Kashiwabara, Kenji ^a   Oyama, Tetsunari ^a   Sano, Takaaki ^a   Fukuda, Toshio ^a   Nakajima, Takashi ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P16; RETINOBLASTOMA PROTEIN; TUMOR MARKER;

ARTICLE; CANCER GRADING; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; DISEASE MARKER; DNA METHYLATION; GENE EXPRESSION REGULATION; GENE MUTATION; GENE REPRESSION; GENE STRUCTURE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CANCER; MARKER GENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; GENES, P16; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; POLYMERASE CHAIN REACTION; RETINOBLASTOMA PROTEIN;

EID: 0031744863     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980619)79:3<215::AID-IJC1>3.0.CO;2-S     Document Type: Article

References (21)

1. BURNS, K.L., UEKI, K., JHUNG, S.L., KOH, J. and LOUIS, D.N., Molecular genetic correlates of p16, cdk4 and pRB immunohistochemistry in giloblastomas. J. Neuropathol. Exp. Neurol. (1997) (In press).
2. CLARK, S.J., HARRISON, J., PAUL, C.L. and FROMMER, M., High sensitivity mapping of methylated cytosines. Nucleic Acids Res., 22, 2990-2997 (1994).
3. GERADTS, J., KRATZKE, R.A., NIEHANS, G.A. and LINCOLN, C.E., Immunohistochemical detection of the cydin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MST1) product gene p16INK4A in archival human solid tumors: Correlation with retinoblastoma protein expression. Cancer Res., 55, 6006-6011 (1995).
4. HAYASHI, N., SUGIMOTO, Y., TSUCHIYA, E., OGAWA, M. and NAKAMURA, Y., Somatic mutation of the MTS (multiple tumor suppressor) gene 1/CDKN4I cyclin-dependent kinase 4 inhibitor) gene in human primary non-small cell lung carcinomas. Biochem. Biophys. Res. Comm., 202, 1426-1436 (1994).
5. HERMAN, J.G., GRAFF, J.R., MYOHANEN, S., NELKIN, B.D. and BAYLIN, S.B., Methylation-specific PCR: A novel PCR assay for methylation status of CpG island. Proc. natl. Acad. Sci. (Wash.), 93, 9821-9826 (1996a)
6. ink4B1. Cancer Res., 56, 722-727 (1996b).
7. HERMAN, J.G., MERLO, A., MAO, L., LAPIDUS, R.G., ISSA, J.-P.J., DAVIDSON, N.E., SIDRANSKY, D. and BAYLIN, S.B., Inactivation of the CDKN2/p16/ MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res., 55, 4525-4530 (1995).
8. KAMB, A., GRUIS, N.A., WEAVER-FELDHAUS, J., LIU, Q., HARSHMAN, K., TAVTIGIAN, S.V., STOCKERT, E., DAY, R.S. III, JOHNSON, B.E. and SKOLNICK, M.H., A cell cycle regulator potentially involved in genesis of many tumor types. Science, 264, 436-440 (1994).
9. KANE, M.F., LODA, M., GAIDA, G.M., LIPMAN, J., MISHARA, R., GOLDMAN, H., JESSUP, J.M. and KOLODNER, R., Methylation of the hMLH1 promoter correlated with lack of expression of hMLH1 in sporadic colon tumor cell lines. Cancer Res., 57, 808-811 (1997).
10. KINOSHITA, I., DOSAKA-AKITA, H., MISHIMA, T., AKIE, K., NISHI, M., HIROUMI, H., HOMMURA, F. and KAWAKAMI, Y., Altered p16INK4 and retinoblastoma protein status in non-small cell lung cancers: Potential synergistic effect with altered p53 protein on proliferative activity. Cancer Res., 56, 5557-5562 (1996).
11. KRATZKE, R.A., GREATENS, T.M., RUBINS, J.B., MADDAUS, M.A., NIEWOEHNER, D.E., NIEHANS, G.A. and GERADTS, J., Rb and p16INK4a expression in resected non-small cell lung tumors. Cancer Res., 56, 3415-3420 (1996).
12. INK4 in human ovarian tumors. Brit. J. Cancer, 76, 146-149 (1997).
13. MERLO, A., HERMAN, J.G., MAO, L., LEE, D.J., GABRFELSON, E., BURGER, P.C., BAYLIN, S.B, and SIDRANSKY, D., 5′CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/ CDKN2/MTS1 in human cancers. Nature (Med.), 1, 686-692 (1995).
14. NAKAGAWA, K., CONRAD, N., WILLIAMS, J.P., JOHNSON, B.E. and KELLY, M. Mechanism of inactivation of CDKN2 and MTS2 in non-small cell lung cancer and association with advanced stage. Oncogene, 11, 1843-1851 (1995).
15. NOBORI, T., MIURA, K., WU, D.J., LOUIS, A., TAKABAYASHI, K. and CARSON, D.A., Deletions of the cyclin-dependent kinase-a inhibitor gene in multiple human cancers. Nature (Lond.), 368, 753-756 (1994).
16. OKAMOTO, A. and 13 OTHERS, Mutations in the p16INK4/MTS1/,p15/MTS2 and p18 Genes in Primary and metastatic lung cancer. Cancer Res., 55, 1448-1451 (1995).
17. OTTERSON, G.A., KHLEIF, S.N., CHEN, W., COXON, A.B. and KAYE, F., CDKN2 gene silencing in lung cancer by DNA hypermethylation and kinetics of p16INK4 protein induction by 5-aza-2′ deoxycystidine. Oncogene, 11, 1211-1216 (1995).
18. REED, A.L., CALIFANO, J., CAIRNS, P., WESTRA, W.H., JONES, R.M., KOCH, W., AHKENDT, S., EBY, Y., SEWELL, D., NAWROZ, H., BARTEK, J. and SIDRANSKY, D.A., High frequency of p 16 (CDKN2/MTS-1/INK4A) in activation in head and neck squamous cell carcinoma. Cancer Res., 56, 3630-3633 (1996).
19. REED, J.A., LOGANZO, F., SHEA, C.R., WALKER, G.J., FLORES, J.F., GLENDENING, J.M., BODGANY, J.K., SHIEL, M.J., HALUSAKA, F.G., FOUNTAIN, J.W. and ALBINO, A.P., Loss of the p16/Cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression. Cancer Res. 55, 2713-2718 (1995).
20. SAKAGUCHI, M., FUJII, Y., HIRAHAYASHI, H., YOON, H.-E., KOMOT, Y., OUE, T., KUSAFUKA, T., OKADA, A. and MATSUDA, H., Inversely correlated expression of p16 and Rb protein in non-small cell lung cancers: an immunohistochemical study. Int. J. Cancer, 65, 442-445 (1996).
21. SERRANO, M., HANNON, G.J., and BEACH, D., A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK 4. Nature (Lond.), 336, 704-707 (1993).